24 February 2014
Genetic screening could help identify men who are most likely to develop an
aggressive form of prostate cancer, a study shows.
The researchers say that men could soon be offered genetic screening for the
disease so that those at greatest risk could be monitored throughout their
lives, while others would avoid unnecessary treatment.
Researchers at the Institute of Cancer Research (ICR) in London examined
blood samples from 191 men with prostate cancer and at least three close
relatives with the disease. They identified 13 mutations, in eight known cancer
risk genes, that greatly increase the risk of developing the most aggressive form of
prostate cancer.
'These results are exciting as they add to the growing weight of evidence
that men with a family history of prostate cancer who possess certain genes may
be at higher risk, providing us with another crucial piece of the jigsaw', said
Dr Iain Frame, director of research at Prostate Cancer UK.
He added: 'Genetic testing to predict risk could revolutionise how we treat
the 40,000 men diagnosed with the disease every year in the UK'.
The discovery suggests that men could be tested for high-risk mutations in the same
way that women are screened for breast cancer risk genes.
Study co-leader Ros Eeles, professor of oncogenics at the ICR, said: 'Although
ours was a small, first-stage study, we proved that testing for known cancer
mutations can pick out men who are destined to have a more aggressive form of
prostate cancer'.
She added: 'We already have the technical capabilities to assess men for
multiple mutations at once, so all that remains is for us to do further work to
prove that picking up dangerous mutations early can save lives. If so, then in
the future genetic testing may be needed as part of the prostate cancer care
pathway'.
BBC News reports that the ICR research group is currently
running a larger prostate cancer screening trial 'involving 2,000 men and
testing 192 genes'.
SOURCES & REFERENCES
|
BBC News
|
21 February 2014
|
|
British Journal of Cancer
|
20 February 2014
|
|
Institute of Cancer Research (press release)
|
21 February 2014
|
|
Prostate Cancer UK
|
21 February 2014
|
|
The Guardian
|
21 February 2014
|
|
The Independent
|
21 February 2014
|
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
|
26 May 2015 - by Dr Julia Hill |
Scientists have announced a comprehensive genetic map of prostate cancer, which they say could lead to new treatments for the advanced stage of the disease... |
|
22 September 2014 - by James Brooks |
A study where the tumour DNA of 16 prostate cancer patients was frequently checked suggests that, in some patients, commonly used anti-cancer drugs may actually boost tumour growth after a while... |
|
15 September 2014 - by Dr Anna Cauldwell |
Twenty-three genetic variants associated with increased risk of prostate cancer have been identified in a new study, bringing the total number of susceptibility variants for the disease to 100... |
|
30 June 2014 - by Dr Nicoletta Charolidi |
A simple blood test that can predict the likelihood of developing non-inherited breast cancer could be developed, following research into the epigenetics of the disease... |
|
14 April 2014 - by Simon Hazelwood-Smith |
A genetic test has been developed to predict the likelihood of prostate cancer returning after treatment. The test looks for 'genetic signatures' often found in recurring cancers... |
|
15 July 2013 - by Julianna Photopoulos |
Scientists have developed a 'barcode' blood test that reads genetic changes to pick out the most aggressive prostate cancers... |
|
13 May 2013 - by Daryl Ramai |
A genetic test released in the USA claims to be able to score the aggressiveness of prostate cancer before medical intervention, helping men with the condition decide if and when to start receiving treatment.... |
|
15 April 2013 - by James Brooks |
Prostate cancer patients who have inherited a well-known gene mutation are more likely to develop an aggressive form of the disease, a study shows... |
|
16 January 2012 - by Dr Linda Wijlaars |
A rare gene variant that could increase the risk of prostate cancer has been identified by researchers in the USA. Although the variant accounts for only a small fraction of all prostate cancers, the study found it was more common in men with an inherited form of the cancer and in those who are diagnosed before the age of 55... |